Esperion Therapeutics (NASDAQ:ESPR) Stock, Earnings Estimates, EPS, And Revenue

Esperion Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 7
EPS
$-0.150
Quarterly Revenue
$51.6M
Annual Revenue
(as of Sep 30)
$295.5M

Analyze the earnings history of Esperion Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Esperion Therapeutics (ESPR) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20242024-11-07$-0.15$-0.1816.7 %
Jun 20242024-08-12$-0.05$-0.1566.7 %
Mar 20242024-05-07$0.34$0.05580.0 %
Dec 20232024-02-27$-0.50$-0.48-4.17 %

Esperion Therapeutics (ESPR) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Sep 20242024-11-07$51.63M$51.32M0.61 %
Jun 20242024-08-12$73.83M$50.59M46.0 %
Mar 20242024-05-07$137.74M$84.51M63.0 %
Dec 20232024-02-27$32.25M$28.70M12.4 %

FAQ

Q

When is Esperion Therapeutics (NASDAQ:ESPR) reporting earnings?

A

Esperion Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Esperion Therapeutics (NASDAQ:ESPR)?

A

Esperion Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.15, which beat the estimate of $-0.18.

Q

What were Esperion Therapeutics’s (NASDAQ:ESPR) revenues?

A

Esperion Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch